NCT04798586 MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT04793399 Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients Status TERMINATED Phase PHASE1/PHASE2
NCT04785612 Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults Status COMPLETED Phase PHASE2
NCT04774094 Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP) Status COMPLETED Phase PHASE4
NCT04767594 First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04766086 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women Status COMPLETED Phase PHASE2
NCT04764487 A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line Status UNKNOWN Phase PHASE3
NCT04756765 Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer Status WITHDRAWN Phase PHASE2
NCT04754594 To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older Status COMPLETED Phase PHASE2/PHASE3
NCT04753658 Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib Status TERMINATED Phase N/A
NCT04748445 Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study. Status COMPLETED Phase N/A
NCT04744532 iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study Status COMPLETED Phase PHASE1/PHASE2
NCT04743141 Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine Status RECRUITING Phase PHASE3
NCT04741997 Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma Status RECRUITING Phase EARLY_PHASE1
NCT04741204 Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Status WITHDRAWN Phase PHASE4
NCT04738266 Unmasking the Prevalence of AC in an Unselected Echocardiographic Population Status UNKNOWN Phase N/A
NCT04736576 Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy Status COMPLETED Phase NA